Omalizumab
Anti-IgE injection for allergic asthma and chronic hives.
- Starts working
- Weeks to months
- Half-life
- About 26 days
- In use since
- —
- Pregnancy
- Use with caution
Overview
Omalizumab binds IgE antibody and is used for severe allergic asthma, chronic spontaneous urticaria and nasal polyps. It is given by injection every 2–4 weeks.
Conditions it's used for
How it works
Blocks the allergy antibody IgE.
Omalizumab belongs to the Asthma biologics. How Asthma biologics work: block specific immune signals that drive severe allergic or eosinophilic asthma.
Uses
- Severe allergic asthma
- Chronic spontaneous urticaria (hives)
- Nasal polyps
- Food allergy (US)
Available as: subcutaneous injection.
Typical dose
- Adults
- 75–600 mg every 2 or 4 weeks, based on body weight and IgE level for asthma; 150–300 mg every 4 weeks for hives.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Injection site reactions
- Headache
- Sore throat
- Joint pain
Serious — get medical help
Uncommon, but need prompt attention
- Anaphylaxis (rare)
- Parasite infection risk
- Heart or stroke events (possible)
Warnings
- Observed after the first doses
- Anaphylaxis can occur hours later
Who should avoid it
- Previous anaphylaxis to omalizumab
Interactions
- No major interactions
Using it safely
- Alcohol
- Usually no problem in moderation. No known interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Contact the clinic as soon as possible.
- Stopping it
- Effect fades over months.
- Driving
- Dizziness or fainting are possible.
- Tests and checks
- Asthma control; Observation after injections
- If too much is taken
- No specific antidote; seek help.
- Storage
- Refrigerate.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Used if needed; data do not show harm.
Breastfeeding
Generally considered safe
Antibodies pass into milk in small amounts.
Special groups
- Kidney disease
- No adjustment.
- Liver disease
- No adjustment.
- Older adults
- Limited data.
Brand names
- United States
- Xolair
- United Kingdom
- Xolair
- India
- Xolair, Omalizumab (generic)
- Australia
- Xolair
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Omalizumab?
Yes — Omalizumab is prescription-only in most countries.
Can I take Omalizumab during pregnancy?
Use with caution. Used if needed; data do not show harm. Always check with a doctor or midwife.
How quickly does Omalizumab work?
Weeks to months.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — R03DX05
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.